Outcome of ultrasound-guided, single session pleurodesis in malignant pleural effusion

被引:3
作者
Magdy, Khalil M. [1 ]
Hieba, Ezzelregal G. [1 ]
机构
[1] Ain Shams Univ, Chest Dept, Cairo, Egypt
关键词
Malignant pleural effusion; Pleurodesis; Chest ultrasound; MANAGEMENT; DIAGNOSIS;
D O I
10.1186/s43168-020-00009-y
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Chemical pleurodesis is frequently indicated to relieve symptoms imposed by large/recurrent malignant pleural effusion (MPE). Traditionally, a drain is left in the pleural space till the cessation of fluid accumulation before pleurodesis. Chest ultrasound can detect an amount of pleural fluid as less as 50 ml and can confirm apposition of the pleural surfaces which is required for successful pleurodesis. This work assessed the efficiency and safety of ultrasound-guided, single-session pleurodesis in cases with MPE. Results Seventeen of the patients completed a 2-month follow-up. The technique demonstrated a high success rate (88.2%). The mean duration from the start of pleural drainage till pleurodesis was 1.65 +/- 0.70 h ranging from 1 to 3 h. A duration of 2.5 h or less was statistically proposed as a cutoff value not to exceed to predict success (sensitivity 100%, specificity 100%). The mean time for total hospital stay related to pleurodesis was 9.88 +/- 3.12 h (range 4-12 h). No complications attributed to the procedure were recorded. Pleural Adherence Score and Absent Sliding Score (ASS) had a highly statistically significant correlation (p value < 0.001). Conclusions An ultrasound-guided completion of the process of pleurodesis in a single session with a shorter duration of pleural fluid drainage and shorter hospital stay (can be done on a day-care basis) is efficient, safe, and cost-effective. This technique is strongly recommended to replace the traditional practice of keeping the indwelling pleural drain for several days waiting for the cessation of pleural fluid reaccumulation. An ultrasound-derived ASS can be used as early as day 1 and day 15 to confirm pleural adherence and to expect the outcome of pleurodesis.
引用
收藏
页数:7
相关论文
共 18 条
  • [1] Management of malignant pleural effusions
    Antony, VB
    Loddenkemper, R
    Astoul, P
    Boutin, C
    Goldstraw, P
    Hott, J
    Panadero, FR
    Sahn, SA
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) : 402 - 419
  • [2] BTS guidelines for the management of malignant pleural effusions
    Antunes, G
    Neville, E
    Duffy, J
    Ali, N
    [J]. THORAX, 2003, 58 : II29 - II38
  • [3] Pleurodesis using different agents in malignant pleural effusion
    Bakr, Ramadan M.
    El-Mahalawy, Ibrahim I.
    Abdel-Aal, Gehan A.
    Mabrouk, Ali A.
    Ali, Ahmed A.
    [J]. EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2012, 61 (04): : 399 - 404
  • [4] Pleural mesothelial cells in pleural and lung diseases
    Batra, Hitesh
    Antony, Veena B.
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (06) : 964 - 980
  • [5] Oral forms of tetracycline and doxycycline are effective in producing pleurodesis
    Bilaceroglu, S
    Guo, YB
    Hawthorne, ML
    Zhu, ZW
    Stathopoulos, GT
    Lane, KB
    Light, RW
    [J]. CHEST, 2005, 128 (05) : 3750 - 3756
  • [6] Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion
    Corcoran, John P.
    Hallifax, Robert J.
    Mercer, Rachel M.
    Yousuf, Ahmed
    Asciak, Rachelle
    Hassan, Maged
    Piotrowska, Hania E.
    Psallidas, Ioannis
    Rahman, Najib M.
    [J]. CHEST, 2018, 154 (05) : 1115 - 1120
  • [7] ULTRASOUND OF THE PLEURAE AND LUNGS
    Dietrich, Christoph F.
    Mathis, Gebhard
    Cui, Xin-Wu
    Ignee, Andre
    Hocke, Michael
    Hirche, Tim O.
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2015, 41 (02) : 351 - 365
  • [8] Hadidy AA, 2017, EGYPT J CHEST DIS TU, V66, P279, DOI 10.1016/j.ejcdt.2016.11.009
  • [9] Diagnosis and management of malignant pleural effusions
    Heffner, John E.
    [J]. RESPIROLOGY, 2008, 13 (01) : 5 - 20
  • [10] JOHNSTON WW, 1985, CANCER-AM CANCER SOC, V56, P905, DOI 10.1002/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO